POWER SPECTRA INC /CA/
10-Q, 1997-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: NOBLE DRILLING CORP, 10-Q, 1997-11-14
Next: YORK FINANCIAL CORP, 10-Q, 1997-11-14




- --------------------------------------------------------------------------------

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 10-Q

(Mark One)
|X|      Quarterly  Report  pursuant  to Section  13 or 15(d) of the  Securities
         Exchange Act of 1934 for the quarterly period ended September 30, 1997

                                       or

|_|      Transition  Report  pursuant  to  Section 13 or 15(d) of the Securities
         Exchange  Act  of 1934 for the transition period from _________________
         to _____________________

                         Commission file number 0-16672

                               Power Spectra, Inc.
             (Exact Name of Registrant as Specified in its Charter)

              California                                       94-2687782
- ---------------------------------------                  -----------------------
    (State or other jurisdiction of                          (IRS Employer
     incorporation or organization)                        Identification No.)

            919  Hermosa Court
               Sunnyvale, CA                                  94086-4103
- ---------------------------------------                  -----------------------
(Address of principal executive offices)                      (Zip Code)

                                 (408) 737-7977
- --------------------------------------------------------------------------------
              (Registrant's telephone number, including area code)

                                 Not applicable
- --------------------------------------------------------------------------------
(Former  name,  former  address and former  fiscal year,  if changed  since last
report)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section  13 or 15 (d) of the  Securities  Act of 1934  during the
preceding  12  months  (or for such  shorter  periods  that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

                           Yes _X_  No ___

         Indicate  the  number of  shares  outstanding  of each of the  issuer's
classes of common stock of the latest practicable date.

                                           Outstanding at
                 Class                   November 13, 1997
            -------------------          -----------------
            Shares of Common                23,869,851
            Stock, no par value

- --------------------------------------------------------------------------------

<PAGE>

Power Spectra, Inc.
Item 1: Financial Statements
<TABLE>
                                                  Balance Sheets
                                                  (In thousands)
<CAPTION>
                                                           September 30, December 31,
Assets:                                                        1997         1996
                                                             --------    --------
<S>                                                          <C>         <C>     
         Current Assets:
                  Cash and cash equivalents                  $    474    $    843
                  Accounts receivable                              42          70
                  Unbilled receivables                              0          26
                  Inventories, principally purchased parts        439         218
                  Other current assets                             32          49
                                                             --------    --------
           Total current assets                                   987       1,206
         Equipment, furniture and
                  leasehold improvements                        1,363       1,355
           Less, accumulated depreciation                      (1,082)       (987)
                                                             --------    --------
           Net fixed assets                                       281         368

         Patents (net of amortization)                             80          73
         Other assets                                              27          26
                                                             --------    --------
Total assets                                                 $  1,375    $  1,673
                                                             ========    ========

Liabilities and stockholders' equity:
         Current liabilities:
                  Accounts payable                           $    168    $    161
                  Accrued compensation expense                    130         145
                  Deferred contract revenue                       433         433
                  Allowance for contract losses                   100         100
                  Accrued professional fees                       113          76
                   Preferred stock dividend payable               192          49
                  Other current liabilities                        28          28
                                                             --------    --------
           Total current liabilities                            1,164         992

Stockholders' equity:
         Preferred stock                                        1,666       1,666
         Common stock                                          15,475      14,078
         Accumulated deficit                                  (16,930)    (15,063)
                                                             --------    --------
Total stockholders' equity                                        211         681
                                                             --------    --------
Total liabilities & stockholders'
         equity                                              $  1,375    $  1,673
                                                             ========    ========

<FN>
See notes to financial statements.
</FN>
</TABLE>

                                        2

<PAGE>

Power Spectra, Inc.
Item 1: Financial Statements

<TABLE>
                                    Statements of Operations
                              (In thousands except per Share data)

<CAPTION>
                                         Nine Months Ended             Three Months Ended
                                  -----------------------------    ----------------------------
                                  September 30,   September 30,    September 30,  September 30,
                                       1997           1996             1997           1996
                                     -------        -------          -------        -------
<S>                                  <C>            <C>              <C>            <C>    
Revenue                              $   668        $   652          $    81        $   294
                                                                  
Costs and expenses:                                               
     Cost of revenue                   1,284          1,830              379            634
     Sales and marketing                 106            292               18             63
     Research and development            274            523              121            276
     General and administrative          742            928              248            292
                                     -------        -------          -------        -------
Total operating costs                  2,406          3,573              766          1,265
                                     -------        -------          -------        -------
Operating loss                        (1,738)        (2,921)            (685)          (971)
Other income                              16             77                3             23
                                     -------        -------          -------        -------
Loss before income taxes              (1,722)        (2,844)            (682)          (948)
Provision for income taxes                 1              1             --             --
                                     -------        -------          -------        -------
Net loss                             $(1,723)       $(2,845)         $  (682)       $  (948)
                                     =======        =======          =======        =======
                                                                  
Net loss applicable to common                                     
 shares                              $(1,866)       $(2,991)         $  (730)       $  (997)
                                     =======        =======          =======        =======
Net loss per common share            $ (0.10)       $ (0.19)         $ (0.04)       $ (0.06)
                                     =======        =======          =======        =======
                                                                
<FN>
See notes to financial statements.
</FN>
</TABLE>

                                                3

<PAGE>



Power Spectra Inc.
Item 1: Financial Statements

                            Statements of Cash Flows
                                 (In thousands)

                                                          Nine Months Ending
                                                     ---------------------------
                                                     September 30, September 30,
                                                           1997       1996
                                                         -------    -------
Cash flows from operating activities:
     Net loss                                           $(1,723)    $(2,845)
     Adjustments to reconcile net loss                           
     to cash used in operating activities:                       
     Depreciation and amortization                          104         107
     Common stock issued for services                        56          69
     Changes in assets and liabilities:                          
         Accounts receivable                                 27         284
         Unbilled receivables                                26          40
         Inventories                                       (221)        (26)
         Other current assets                                17          (5)
         Accounts payable                                     7          15
         Accrued compensation expense                       (15)         22
         Preferred stock dividend payable                   143        --
         Deferred contract revenue                         --           379
         Other current liabilities                           37         (25)
                                                        -------     -------
    Net cash used in operating activities                (1,542)     (1,985)
Cash flows from investing activities                             
   Furniture and equipment additions and disposals, net    --           (60)
   Patent additions                                         (24)        (25)
   Increase in other assets                                  (1)         (6)
                                                        -------     -------
   Net cash used in investing activities                    (25)        (91)
Cash flows from financing activities                             
     Preferred stock dividend                              (143)       (146)
     Proceeds from sale of common stock                   1,341       2,063
                                                        -------     -------
     Net cash used in financing activities                1,198       1,917
                                                        -------     -------
Net increase (decrease) in cash and cash equivalents       (369)       (159)
Cash and cash equivalents, beginning of period              843       2,395
                                                        -------     -------
Cash and cash equivalents, end of period                $   474     $ 2,236
                                                        =======     =======
Supplemental schedule of cash flow information:                  
    Cash paid during the period for:                             
         Interest                                       $  --       $     1
                                                        =======     =======
         Income taxes                                   $     1     $     1
                                                        =======     =======
See notes to financial statements.

                                        4

<PAGE>


                               Power Spectra Inc.
                          Notes to Financial Statements
                               September 30, 1997

1. Basis for Presentation:

     The  accompanying  unaudited  financial  statements  have been  prepared in
accordance with generally accepted  accounting  principles for interim financial
information and with the  instructions to Form 10-Q and Article 10 of Regulation
S-X.  Accordingly,  they do not include  all of the  information  and  footnotes
required by generally  accepted  accounting  principles  for complete  financial
statements. In the opinion of management,  all adjustments (consisting of normal
recurring  accruals)  considered  necessary  for a fair  presentation  have been
included.  Operating  results for the nine month period ended September 30, 1997
are not necessarily  indicative of the results that may be expected for the year
ending December 31, 1997. For further  information,  refer to "Factors Affecting
Future Results, " and to the financial statements and footnotes thereto included
in the  Company's  Annual  Report on Form 10-K for the year ended  December  31,
1996.

2.  Per Share Data:

     Per share  information for the quarter ended September 30, 1997 is computed
based on the net loss  after  deducting  Series A and Series B  Preferred  Stock
dividends in 1997. The weighted average number of shares outstanding consists of
the common stock. The effect of common stock  equivalents which would arise from
the  exercise  of common  stock  options  and  warrants  outstanding  (using the
treasury  stock  method) and the  conversion  of Series A and Series B Preferred
Stock have not been  included  for the  quarter  and for the nine  months  ended
September 30, 1997 and September 30, 1996, as their effect is anti-dilutive. The
weighted  average  number  of  shares  outstanding  at  September  30,  1997 and
September 30, 1996 were  18,934,600 and  15,402,445,  respectively  for the nine
month periods,  and were 20,693,088 and 16,058,190,  respectively  for the third
quarter periods.

3.  Common Stock:

     On  September  30, 1997 the Company  closed the first  tranche of a private
placement  of its common stock with a maximum  gross  proceeds to be raised from
the offering of  $1,200,000.  Gross proceeds  raised through  September 30, 1997
were  $340,500.  The  Company  has  agreed  to use its  best  efforts  to file a
registration  statement  covering the resale of Shares offered within 60 days of
the  completion  of  the  offering  and  to  use  its  best  efforts  to  obtain
effectiveness  thereof as promptly as possible  thereafter.  If the registration
statement is not  effective  within 120 days of the final  closing,  the Company
will issue additional  shares of Common  Stock to the  investors in an aggregate
dollar amount equal to 2% of the gross proceeds  received in the offering at the
original issue price of $0.375, for each 30-day delay in such effectiveness.

     The placement  closed  November 13, 1997.  Gross  proceeds  raised  through
November 13, 1997 were  $1,200,000.  The Company agreed to pay a selling agent a
cash  placement  fee  equal to 8% of the  gross  proceeds  of the  offering.  In
addition, the Company has

                                        5

<PAGE>

agreed to issue the setting agent Warrants to purchase Common Stock  exercisable
for a number of shares  equal to 5% of the  total  number of shares  sold in the
offering.  The selling agent's  Warrants will be exercisable at $0.375 per share
(equal to the offering price of the shares) and will be exercisable for a period
of five years commencing on the earlier of one year from the date of issuance or
the effective date of the registration  statement  covering the resale of shares
issuable upon exercise of such warrants.  In recognition of financial consulting
services previously  rendered,  the Company has agreed to sell the selling agent
additional  five-year  Common  Stock  purchase  warrants,  entitling  the holder
thereof to purchase up to an aggregate of an additional 160,000 shares of Common
Stock at an exercise  price of $0.375 per share.  The  purchase  price for these
warrants is $400.  The shares  issuable  upon  exercise of the warrants  will be
included in the registration statement to be filed on behalf of the investors.

                                        6

<PAGE>

Power Spectra Inc.
Item 2:

                Management's Discussion and Analysis of Financial
                       Condition and Results of Operations

     This  Report  contains  forward-looking  statements  within the  meaning of
Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and
Section 21E of the  Securities  Exchange Act of 1934, as amended (the  "Exchange
Act"). The  forward-looking  statements  contained herein are subject to certain
risks and  uncertainties,  including those discussed herein and in the Company's
Annual  Report on Form 10-K for the fiscal year ended  December 31,  1996,  that
could  cause  actual  results  to differ  materially  from  those  projected  or
discussed.  Investors  are  cautioned  not to  place  undue  reliance  on  these
forward-looking  statements,  which reflect management's analysis only as of the
date  hereof.  The Company  undertakes  no  obligation  to publicly  release the
results of any revision to these forward-looking  statements that may be made to
reflect  events  or  circumstances  after  the date  hereof  or to  reflect  the
occurrence of  unanticipated  events.  For the  convenience  of the reader,  the
Company has attempted to identify  forward-looking  statements contained in this
report with an asterisk (*). However,  the omission of an asterisk should not be
presumed to mean that a statement is not a forward looking  statement within the
meaning of Section 27A of the  Securities  Act and  Section 21E of the  Exchange
Act.

Results of Operations:

     Revenues for the three months and nine months ended September 30, 1997 were
$81,000  and  $668,000,   respectively,   compared  to  $294,000  and  $652,000,
respectively,  for the same periods  ended  September  30, 1996,  an decrease of
$113,000 for the quarterly  period and an increase of $16,000 for the nine-month
period,  respectively.  Revenues  in the  first  nine  months  of 1997  from the
Company's $1,200,000 contract with LandRay Technologies, Inc. (LandRay), a joint
venture partially owned by the Company, were $500,000, or 75% of total revenues.
Revenues from a contract from the U.S. Air Force were $242,000,  or 37% of total
revenues,  and revenues  from an earlier  contract with LandRay were $293,000 or
45% of total  revenues,  in the first nine months of 1996.  Revenues  from other
contracts  and  products  increased  by $51,000 in the first nine months of 1997
from the same period in 1996.

     The 1997 third quarter net loss was  $682,000,  a decrease of $266,000 over
the net loss of  $948,000  recorded  in the 1996  third  quarter.  A net loss of
$1,723,000 was recorded for the first nine months of 1997 compared to a net loss
of $2,845,000 for the same period in 1996.  This decrease was  attributable to a
$1,167,000  decrease in expenditures,  and a $16,000 increase in revenues offset
by a $61,000 decrease in interest income.

     The cost of revenue decreased by $255,000 for the third quarter of 1997 and
decreased by $546,000 for the first nine months of 1997 over the same periods in
1996  due  to  reduced  overhead  expenditures.  Sales  and  marketing  expenses
decreased by $45,000 and  $186,000  for the third  quarter and first nine months
ended  September  30,  1997,  respectively,  over the same  periods in 1996 as a
result of reduced personnel, consulting, and travel costs. The 1997 research and
development

                                        7

<PAGE>

expenses  decreased by $155,000 for the third  quarter and decreased by $249,000
for the  first  nine  months  over  the  same  periods  in 1996  due to  reduced
expenditures   on   consulting   and  other   outside   services.   General  and
administrative  costs also  decreased  by  $44,000  and  $186,000  for the third
quarter and first nine months of 1997 from 1996 levels due  primarily to reduced
personnel costs.

     Other income  decreased in the third  quarter and first nine months of 1997
compared to the same period of 1996 by $20,000 and $61,000,  respectively,  as a
result of lower interest income.

Liquidity and Capital Resources:

     During the 1997 first nine months,  cash and cash equivalents  decreased by
$369,000  due to  the  net  loss  from  operations,  increased  receivables  and
inventories offset by the sale of common stock. Accounts receivable and unbilled
receivables  increased  by  $53,000  net,  or 42%,  as  combination  of  product
shipments, moving unbilled to billed receivables, and milestone completion under
the LandRay contract.  Inventories increased by 101%, or $221,000, from December
31, 1996, in anticipation of increased  industrial  product sales. Other current
assets  decreased by $17,000  primarily due to  expiration of prepaid  insurance
during the period.

     Accounts  payable  decreased  40% from  December  31,  1996,  to $97,000 at
September  30,  1997 due  primarily  to reduced  operating  costs.  The  accrued
compensation  expense  balance  increased by $15,000,  an 11% increase  over the
balance  at  December  31,  1996,   primarily  due  to  the  timing  of  payroll
expenditures.  The  $143,000  increase  in  other  current  liabilities  was due
primarily to deferral to later periods of the accrued  dividends on the Series A
and Series B Preferred Stock.

     Backlog at  September  30,  1997,  was  $717,145 of which 98%  consisted of
commitments  under the  LandRay  contract as opposed to the  September  30, 1996
where  backlog was $381,670 of which 67% was  commitments  under a prior LandRay
contract.  Management  expects the current  LandRay  contract to be completed by
February 28,  1998*,  although  there is no assurance  that the contract will be
completed on this schedule.

As part of the  terms of the  research  agreement  between  The  Boeing  Company
("Boeing")  and Power Spectra,  whose active period  extended from 1989 to 1996,
Boeing  provided  equipment  for  Power  Spectra's  use in  that  research.  The
equipment,   principally   purchased   between  1991  and  1993,   had  a  price
approximating  $2,800,000.  Upon  termination  of  the  active  portion  of  the
agreement  in 1996,  Boeing and Power  Spectra  amended the  agreement  to allow
continued rent free use of the equipment so long as Power Spectra maintained the
equipment   within  the  facility  which  Power  Spectra  leases  from  Boeing's
subsidiary,  ARGOSystems,  Inc., and insured it for replacement value, nominally
$2,800,000.  A  significant  portion of the  research  agreement  equipment  was
incorporated   into  or  used   in   conjunction   with   systems   which   were
semi-permanently  attached to the  facility.  Upon  termination  of the facility
lease,  Power  Spectra  was  required to restore  the  premises to its  original
condition with allowance for reasonable wear and tear. Since Power Spectra could
not restore the facility to original condition without removal of the equipment,
and could not remove the equipment  for which it did not have title,  Boeing and
Power Spectra,  on 17 September 1997, again modified the research agreement with
respect to the  equipment,  thereby  transferring  title to the  equipment  from
Boeing to Power Spectra.  Power Spectra is responsible  for any taxes related to
the transfer and ongoing possession of the equipment, and for

                                        8

<PAGE>

the  equipment's  removal and/or  disposal from the premises leased at or before
the  termination  of the  lease,  and for  restoration  of the  premises  to its
original condition with allowance for reasonable wear and tear.

     On  September  30, 1997 the Company  closed the first  tranche of a private
placement  of its common stock with a maximum  gross  proceeds to be raised from
the offering of  $1,200,000.  Gross proceeds  raised through  September 30, 1997
were  $340,500.  The  Company  has  agreed  to use its  best  efforts  to file a
registration  statement  covering the resale of Shares offered within 60 days of
the  completion  of  the  offering  and  to  use  its  best  efforts  to  obtain
effectiveness  thereof as promptly as possible  thereafter.  If the registration
statement is not  effective  within 120 days of the final  closing,  the Company
will issue  additional  shares of Common Stock to the  investors in an aggregate
dollar amount equal to 2% of the gross proceeds  received in the offering at the
original issue price of $0.375, for each 30-day delay in such effectiveness.

The placement  closed November 13, 1997.  Gross proceeds raised through November
13, 1997 were  approximately  $1,200,000.  The  Company  agreed to pay a selling
agent a cash placement fee equal to 8% of the gross proceeds of the offering. In
addition, the Company has agreed to issue the setting agent Warrants to purchase
Common Stock  exercisable for a number of shares equal to 5% of the total number
of shares sold in the offering. The selling agent's Warrants will be exercisable
at $0.375 per share  (equal to the  offering  price of the  shares)  and will be
exercisable  for a period of five years  commencing  on the  earlier of one year
from the date of issuance or the effective  date of the  registration  statement
covering  the resale of shares  issuable  upon  exercise  of such  warrants.  In
recognition of financial  consulting services previously  rendered,  the Company
has agreed to sell the selling agent additional  five-year Common Stock purchase
warrants,  entitling  the holder  thereof to purchase up to an  aggregate  of an
additional  160,000  shares of Common  Stock at an exercise  price of $0.375 per
share.  The purchase price for these warrants is $400. The shares  issuable upon
exercise of the warrants  will be included in the  registration  statement to be
filed on behalf of the investors.

Factors Affecting Future Results:

     The  actual  amount  of time  that the  Company's  cash  resources  last is
dependent  upon a variety  of factors  including  the  timing of  obtaining  new
contracts,  the  timing of new  financings,  the  success of its  current  joint
ventures  and the  competition  with other  vendors.  The Company has  commenced
efforts to obtain  additional  equity  financing.  If any  additional  funds are
raised through the issuance of equity  securities,  the percentage  ownership of
the  shareholders  of the Company will be reduced,  shareholders  may experience
significant dilution and such equity securities may have rights,  preferences or
privileges  senior  to those of the  Company's  Common  Stock.  There  can be no
assurance that  additional  financing  will be available,  or that if available,
such  financing  will  have  terms  favorable  to the  Company  or  its  present
shareholders. Any failure to secure adequate funding could result in the Company
becoming  unable to meet its  obligations as they come due. In addition,  if the
Company is not  successful  in replacing  the revenue and cash  generated by the
LandRay contract when it expires, the Company as presently sized, would continue
to experience  substantial operating losses. The Company does not presently have
access to any credit facilities.

     History of Losses;  Accumulated Deficit.  Since its inception,  the Company
has generally operated

                                        9

<PAGE>

at a loss  since  government  contract  revenues,  which  represent  most of the
historical   revenues  of  the  Company,   and  other  sources  of  income  were
insufficient to cover general and  administrative,  research and development and
other  costs  incurred  by the  Company.  The  Company  recorded  net  losses of
($3,788,299),  ($2,562,230)  and  ($1,112,507)  for the years ended December 31,
1996,  December 31, 1995 and December  31, 1994,  respectively.  At December 31,
1996, the Company had an accumulated deficit of $15,062,956, which had increased
to $16,930,000 at September 30, 1997. The Company  expects that it will continue
to incur  losses  for the  foreseeable  future  and does not  expect  to  become
profitable  until its  contract  revenues  increase  substantially  from current
levels or the Company  begins to receive  significant  product sales and license
and/or  royalty  income.  There is no  assurance  that the Company  will achieve
profitable operations in the foreseeable future, if at all.

Dependence upon the LandRay  Contract.  The Company's  relationship with LandRay
has been a significant source of revenues since the first contact was awarded to
the Company in 1996.  Should the current contract with LandRay terminate for any
reason, it would be necessary to find alternative sources of revenue,  and there
is no assurance  that the Company  would be  successful  in  accomplishing  this
result.  If the  Company is not  successful  in  replacing  the revenue and cash
generated by the LandRay  contracts,  the Company,  will  continue to experience
significant  operating losses and significant  negative cash flow.  Although the
Company has  substantially  reduced the size of its operations over the last two
years,  there can be no assurance that the Company's  revenues and proceeds from
the equity  financings  will be  sufficient  to allow the Company to support its
operating expenses.

Need to Successfully Launch and Fund New Ventures.  The Company believes it must
continue to seek and obtain  other  sources of revenue to  continue  operations.
Since  its  inception  nearly  all of the  Company's  revenues  have  come  from
defense-related   research  and  development   contracts  related  to  the  BASS
development and  applications.  The Company  currently is seeking to exploit its
technology in industrial applications. In the commercial and industrial markets,
the Company has identified a number of promising,  new applications that include
radar systems for gathering high  resolution  data on underground  pipelines and
other utilities,  laser-based measurement systems, hazardous waste detection and
subterranean oil and mineral detection for geological  exploration.* During 1996
the Company entered into two joint ventures, LandRay Technologies, Inc. and PEAC
Airborne  Technologies,  Ltd.,  in order to develop  and  exploit  new  business
opportunities   which  the  Company   believes  are  possible   based  upon  its
ultra-wideband  ground penetrating radar ("UWB GPR") technology.  As of the date
hereof,  the PEAC  venture has not been funded and it  continues to seek initial
funding.  However the Company's venture with LandRay has progressed during 1997.
The  purpose of the  LandRay  venture is to develop  UWB GPR  systems for remote
sensing,  detection,  location and imaging of  subterranean  metal  deposits and
geophysical  profiles to aid in the  exploration  of minerals and fossil  fuels.
Among  LandRay's  objectives  are to (i) prove the  feasibility of the Company's
proprietary impulse generator  technology for the exploration of metal,  mineral
and oil and gas  formations,  and (ii)  develop  and exploit  systems  using the
Company's  technology.  To date the Company has been  successful  in meeting the
established  technical  milestones under its contract with LandRay. On 9 October
1997, the Company announced that it had located gold deposits through eight feet
of quartz  and that its finds  exceeded  100 troy  ounces.  To date,  finds have
exceeded 200 troy ounces of gold. There is no assurance,  however,  that LandRay
and the Company  will  continue to be  successful  in this  regard,  or that the
technology and equipment can be successfully  applied to commercial  operations.
Failure of LandRay and the Company to continue to  adequately  demonstrate  such
feasibility and thus garner new business, will have a

                                       10

<PAGE>

material adverse impact on the Company's  revenues and cash flows. Both the PEAC
and LandRay  ventures  will  require  additional  funding in order to enable the
Company and its joint venture  partners to carry out their  respective  plans of
operations. There can be no assurances that the proposed PEAC joint venture will
be  consummated,  that the PEAC and LandRay joint ventures will be able to raise
adequate  funding  on  acceptable  terms,  that  the  Company  will  be  able to
successfully  enter into any  additional  suitable  partnership or joint venture
arrangements  or that such  arrangements,  when entered  into,  will prove to be
beneficial for the Company and its shareholders.  There also can be no assurance
that the proposed  joint  venture  agreements,  if  consummated,  will  generate
sufficient  revenues to replace the existing  LandRay  contract when it expires.
Failure  to  succeed  in one or more  strategic  partnerships  or joint  venture
relationships  could have a material  adverse  effect on the  Company's  plan of
operations and results.

     Volatility  of Stock Price.  The market price of the Common Stock is highly
volatile.  Factors such as  variations in the  Company's  operating  results and
announcements of  technological  innovations or price reductions by the Company,
its competitors or providers of alternative products and processes may cause the
market price of the Common Stock to fluctuate  substantially.  In addition,  the
securities  markets  have  recently  experienced  substantial  price and  volume
fluctuations that have particularly  affected  technology-based  companies,  and
resulted in changes in the market  prices of the stocks of many  companies  that
have not been directly related to the operating  performance of those companies.
The price of the Company's  Common Stock is particularly  susceptible to extreme
fluctuation  because  of thin  trading  volume in the  Common  Stock and lack of
widely available pricing information.

                                       11

<PAGE>

Power Spectra Inc.
Part II -  Other Information


ITEM 1.           LEGAL PROCEEDINGS.

                  None.

ITEM 2.           CHANGES IN SECURITIES.

                  On September 30, 1997, October 31, 1997 and November 13, 1997,
                  the Company  issued an aggregate  of  3,200,000  shares of its
                  Common  Stock to certain  investors,  for an  aggregate  gross
                  purchase  price of  $1,200,000.  The Company  employed  Morgan
                  Fuller  Capital Group as placement  agent in  connection  with
                  this transaction.  The Company agreed to pay the selling agent
                  and its  sub-agents  a cash  placement  fee equal to 8% of the
                  gross proceeds of the  transaction.  The Company has agreed to
                  issue to the selling agent warrants  exercisable  for a number
                  of shares of Common  Stock equal to 5% of the total  number of
                  shares sold in the offering.  In addition,  in  recognition of
                  financial consulting services previously rendered, the Company
                  has  agreed to sell the  selling  agent  additional  five-year
                  Common Stock purchase  warrants,  entitling the holder thereof
                  to purchase up to an aggregate of an additional 160,000 shares
                  of Common Stock at an exercise price of $0.375 per share.  The
                  purchase  price for these  warrants  is $400.  The Company has
                  agreed to  register  for  resale  the  shares of Common  Stock
                  issued  in the  private  placement,  as  well  as  the  shares
                  issuable upon exercise of the selling  agent's  warrants.  The
                  Common  Stock  was  issued  without   registration  under  the
                  Securities  Act in reliance on Section 4(2) of the  Securities
                  Act and Regulation D promulgated thereunder.

ITEM 3.           DEFAULTS UPON SENIOR SECURITIES.

                  None.

ITEM 4.           SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

         a.       The  Company  held its  Annual  Meeting of  Shareholders  (the
                  "Meeting")  on July 25, 1997.  Proxies were  solicited for the
                  Meeting.

         b.       At the Meeting,  the following directors were elected:  Harold
                  T. Bowling,  James A Glaze,  Jay W. Hubbard,  Gene J. Kennedy,
                  James A. Lovell, Jr., John W. Pauly, and Gordon H. Smith.


                                       12

<PAGE>




<TABLE>
         c.       The following matters were voted upon as indicated.

                  Election of Directors
<CAPTION>
                                                           Number of Votes               Elected For
                                                     --------------------------         -------------
                  Name                                    For          Withheld         One Year Term
                  ----                               ------------      --------         -------------
<S>               <C>                                 <C>                  <C>                   <C> 
                  Harold T. Bowling                   17,539,674           537,525               Yes
                  James A. Glaze                      17,540,474           536,725               Yes
                  Jay W. Hubbard                      17,538,154           539,045               Yes
                  Gene J. Kennedy                     17,500,104           577,095               Yes
                  James A. Lovell, Jr.                17,539,754           537,445               Yes
                  John W. Pauly                       17,506,074           571,125               Yes
                  Gordon H. Smith                     17,541,154           536,045               Yes
</TABLE>

<TABLE>
                  Approval of Amendment to Articles of Incorporation
<CAPTION>
                                                              Number of Votes
                  ---------------------------------------------------------------------------------------
<S>               <C>      <C>              <C>               <C>               <C>               <C>    
                  For:     13,385,444       Against:          4,556,654         Abstained:        135,101
                           ----------                         ---------                           -------


                  Approval of Amendment to 1991 Director Stock Plan

                                                              Number of Votes
                  ---------------------------------------------------------------------------------------
                  For:     16,225,702       Against:          1,634,858         Abstained:        216,639
                           ----------                         ---------                           -------


                  Ratification of Grant Thornton
                                                              Number of Votes
                  ---------------------------------------------------------------------------------------
                  For:     17,832,657       Against:          26,912            Abstained:        217,630
                           ----------                         ------                              -------
</TABLE>


ITEM 5.           OTHER INFORMATION.

                  None.

ITEM 6.           EXHIBITS AND REPORTS ON FORM 8-K

         a.       Exhibits

                  10.1      Research Agreement between Registrant and The Boeing
                            Company, as amended September 17, 1997

                  27.1      Financial Data Schedule

         b.       Reports on Form 8-K during the  quarter  ended  September  30,
                  1997

                  During the period covered by this report,  the Company did not
                  file any reports on Form 8-K.

                                       13

<PAGE>

                               Power Spectra Inc.
                               September 30, 1997




                                   Signatures



         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                                         Power Spectra Inc.



         Date: November 14, 1997                   By:   /s/ Edward J. Lamb
               ------------------                        -----------------------
                                                         Edward J. Lamb
                                                         Chief Financial Officer



                                       14

<PAGE>

                                  Exhibit Index


Exhibit
   No.            Description
- -------           ------------
10.1              Research  Agreement  between  the  Registrant  and The  Boeing
                  Company, as amended 17 September 1997

27.1              Financial Data Schedule

                                       15




                                                                    Exhibit 10.1


                             AMENDMENT NUMBER 12 TO
                        RESEARCH AGREEMENT 9-1110-JET-103


This  AMENDMENT,  designated as AMENDMENT  Number 12,  effective as 17 September
1997, is entered by and between POWER SPECTRA,  INC., having a place of business
n  Sunnyvale,  California  (hereinafter  referred  to as "PSI")  and THE  BOEING
COMPANY,  (including its subsidiaries and affiliates) acting through its Defense
& Space Group,  having a place of business at Seattle,  Washington  (hereinafter
referred to as "BOEING").

WHEREAS,  the  parties  have  previously  entered  into  that  certain  Research
Agreement  9-1110-JET-103 dated September 21, 1989, and Amendments 1-11 thereto;
and

WHEREAS,  since 1990,  PSI has used on its  premises  certain  capital and other
equipment owned by Boeing, all such equipment being now identified in Attachment
A hereto; and

WHEREAS,  PSI is currently leasing  commercial  facilities and office space from
ARGOSystems,  Inc.,  a  wholly  owned  subsidiary  of  Boeing,  pursuant  to the
ARGOSystems/PSl Lease Agreement dated 22 November 1991, as amended;

WHEREAS,  BOEING  wishes to  transfer to PSI,  the  capital and other  equipment
identified in Exhibit A, for no consideration  except as described  herein,  and
PSI wishes to accept such capital and other  equipment under the terms described
herein;

NOW, THEREFORE, the parties hereto agree as follows:

1. Notwithstanding any other provision of Research Agreement 9-1110-JET-103,  as
amended,  effective on the date of this Amendment,  BOEING transfers fulI title,
conveys,  and gives to PSI, for the consideration  described herein, the capital
and the other equipment described in Attachment A.

2. PSI is  accepting  this  equipment  for use and not for  scrap  or  disposal.
Nonetheless,  PSI assumes all responsibility to dispose of any capital and other
equipment of  Attachment  which It may not wish to retain,  such  disposal to be
fully compliant with all federal, State, local, and community laws, regulations,
and  requirements,  at no  cost  or  expense  to  BOEING  or  ARGOSystems.  Upon
termination of the ARGOSystems/PSI  lease agreement dated 22 November 1991, PSI,
as owner of the capital and other equipment in Attachment A, shall remove it all
completely  from the leased  premises,  restoring  such promises to its original
condition  (with  allowance for reasonable wear and tear), at no cost or expense
to BOEING or to ARGOSystems.

3. DISCLAIMER.  PSI accepts this equipment "AS IS" and without any warranty. PSI
HEREBY WAIVES ALL OTHER WARRANTIES, GUARANTEES, OBLIGATIONS. LIABILITIES, RIGHTS
AND REMEDIES, EXPRESS OR IMPLIED, ARISING BY LAW OR OTHERWISE, INCLUDING BUT NOT
LIMITED TO THE IMPLIED WARRANTY OF MERCHANTABILITY, ANY IMPLIED WARRANTY ARISING
FROM  COURSE OF  PERFORMANCE,  COURSE OF DEALING OR USAGE OR TRADE,  ANY IMPLIED
WARRANTY  OF  FITNESS,   AND  ANY   OBLIGATION  OR  LIABILITY  OF  BOEING,   ITS
SUBSIDIARIES,  AFFILIATES  (AND RESPECTIVE  DIRECTORS,  OFFICIERS AND EMPLOYEES)
ARISING FROM TORT, OR FOR LOSS OFUSE,  REVENUE OR PROFIT,  OR FOR  INCIDENTAL OR
CONSEQUENTIAL DAMAGES.


<PAGE>

Page 2, Amendment 12 to Research Agreement 9-1110-JET-103


4. SPECIAL TERMS REGARDING  HAZARDOUS  SUBSTANCES AND/OR RADIOACTIVE  MATERIALS.
The  capital  and  other  equipment  may  contain  hazardous  substances  and/or
radioactive  materials which,  upon the end of the equipment's  useful life, may
require special handling for final disposition.

Release.  PSI has  satisfied  itself  regarding the condition of the capital and
other equipment covered by this Agreement.  Upon taking title of this equipment,
PSI hereby agrees to assume complete  responsibility  for handling,  management,
transport,  and use of the capital and other  equipment,  and if  undertaken  by
Power  Spectra,  the removal and  disposal of any  hazardous  substances  and/or
radioactive  materials therein or thereon,  in accordance with existing federal,
state  and  local  laws and  regulations.  Power  Spectra  further  assumes  all
responsibility to provide  appropriate  personal protective measures for itself,
its  employees,  agents and assigns,  as well as any third  parties  potentially
exposed  to any  hazardous  substances  and/or  radioactive  materials  from the
capital and other equipment.  PSI releases The Boeing Company. its subsidiaries,
affiliates and their respective directors,  officers, employees, agents from any
and all  liability  arising from or related to the hazardous  substances  and/or
radioactive  materials  now  contained in or on the capital and other  equipment
obtained hereunder.

Indemnity.  PSI shall defend, indemnify and hold harmless The Boeing Company, Re
subsidiaries,  affiliates and their respective directors,  officers,  employees,
agents (hereinafter referred to as "INDEMNITIES"') from and against all actions,
causes of action, liabilities.  claims, liens. suits. judgments,  awards, fines,
penalties,  and damages, of any kind and nature whatsoever brought or claimed by
Boeing or any other party and expenses and costs of litigation  and counsel fees
related  thereto,  or incident  to  establishing  the right to  indemnification,
arising out of or in any way connected with any cleanup, containment,  remedial,
removal or restoration work required or performed by any federal, state or local
governmental   agency   or   political   subdivision,   or   performed   by  any
non-govemrmntal entity or person,  including The Boeing Company,  because of the
presence or suspected  presence,  release or threatened or suspected  release of
hazardous substances and/or radioactive  materials in or into the environment at
on about under or within any property or any disposal site used by PSI, relating
to the capital  equipment and any claims of third parties for loss,  injury,  or
damage to persons or property arising from or related to any residual  hazardous
substances  and/or  radioactive  materials now contained in or on the capital or
other equipment obtained hereunder.

5. All other  provisions  of the Research  Agreement of September  21, 1989,  as
amended, shall remain unchanged.

IN WITNESS WHEREOF,  the authorized  representatives  of the parties hereto have
executed this Amendment No. 12 in duplicate originals.


The Boeing Company                              Power Spectra, Inc.
Defense & Space Group

By:            J.C. Hart                         By:           E. J. Lamb
   ----------------------------------               ----------------------------
               J. C. Hart                                      Edward Lamb

Title:         Contracts Manager                 Title:        Contracts Manager
               Research & Technology

Date:          9-12-97                           Date:         9-17-97



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This  schedule  contains  summary  financial   information  extracted  from  the
financial statements in the Quarterly Report on Form 10-Q of Power Spectra, Inc.
for the nine months ended September 30, 1997 and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
<CIK>                                        0000777527
<NAME>                              Power Spectra, Inc.
<MULTIPLIER>                                      1,000
<CURRENCY>                                          USD
       
<S>                               <C>
<PERIOD-TYPE>                     9-MOS
<FISCAL-YEAR-END>                           DEC-31-1997
<PERIOD-START>                              DEC-31-1996
<PERIOD-END>                                SEP-30-1997
<EXCHANGE-RATE>                                       1
<CASH>                                              474
<SECURITIES>                                          0
<RECEIVABLES>                                        42
<ALLOWANCES>                                          0
<INVENTORY>                                         439
<CURRENT-ASSETS>                                    987
<PP&E>                                            1,363
<DEPRECIATION>                                    1,082
<TOTAL-ASSETS>                                    1,375
<CURRENT-LIABILITIES>                             1,164
<BONDS>                                               0
<COMMON>                                         15,475
                                 0
                                       1,666
<OTHER-SE>                                     (16,930)
<TOTAL-LIABILITY-AND-EQUITY>                      1,375
<SALES>                                             668
<TOTAL-REVENUES>                                    668
<CGS>                                             1,284
<TOTAL-COSTS>                                     2,406
<OTHER-EXPENSES>                                      0
<LOSS-PROVISION>                                      0
<INTEREST-EXPENSE>                                    0
<INCOME-PRETAX>                                 (1,722)
<INCOME-TAX>                                          1
<INCOME-CONTINUING>                             (1,723)
<DISCONTINUED>                                        0
<EXTRAORDINARY>                                       0
<CHANGES>                                             0
<NET-INCOME>                                    (1,723)
<EPS-PRIMARY>                                    (0.10)
<EPS-DILUTED>                                    (0.10)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission